In 2005, the world's wealthiest nations committed to providing universal access to HIV/ AIDS treatment by 2010. Two and half years later, the prospect of this goal being realized is remote. This months G8 nations summit must be used to revitalize their commitment to AIDS treatment, prevention and care.
each of the G8 member nations must ensure that the upcoming 2007 G8 process…is used to place HIV/ AIDS treatment access back on top of the agenda Last year, over 4 million new HIV infections were recorded worldwide. Three million of these infections occurred in sub-Saharan Africa, a region which continues to bear the brunt of the global epidemic. Indeed, two thirds of all adults and children with HIV live in sub-Saharan Africa and despite declines in national HIV prevalence in some countries within the region, these downward trends are currently neither strong nor widespread enough to diminish the tragic scale of the epidemic, a plague that is reversing decades of social and economic development. Perhaps the most tragic aspect of this disaster is that it is largely unnecessary -in developed countries highly active antiretroviral therapy (HAART) has greatly reduced the rate of HIV infection and has curtailed the spread of the epidemic, yet access to these treatment opportunities is severely limited in the regions of the world that are most affected.
Clearly, implementation of a strategy that makes effective treatment accessible to those living in sub-Saharan Africa and other under-developed regions is one obvious component of an overall solution. Indeed, it was obvious enough for the leaders of the group of 8 (G8) nations at the Gleneagles summit in 2005 to commit to ensuring that "as close as possible" there would be universal access to HIV/AIDS treatment and prevention programmes by 2010. This commitment, coming shortly after the WHO's unfulfilled goal of treating 3 million HIVinfected people by 2005 (3 × 5), was widely publicized and universally welcomed as providing both much needed impetus and a framework for reducing the impact of the disease and curbing the spread of the HIV pandemic. Now, two and half years later -and half way towards the 2010 deadline -how close are we to "as close as possible"? Not close at all, according to the latest HIV/ AIDS treatment access numbers recently released by the WHO. Although treatment access has grown by approximately 700,000 to about 2 million patients worldwide over the last 12 months, at the current rate of expansion, there will be a shortfall in meeting the internationally accepted target of 9.8 million patients on treatment by 2010 -a staggering shortfall that could number five million people 1 . Equally concerning are the unmistakable signs suggesting that much of the momentum and goodwill gained from the original WHO 3 × 5 campaign and the subsequent G8 commitments are being lost and the ongoing efforts to scale-up the provision of HIV/ AIDS treatments are languishing.
The problems are numerous. Only 26 of over 100 countries that set targets have developed costed national plans for key HIV/AIDS interventions -a 75% failure rate to achieve the first agreed milestone that speaks volumes about a lack of commitment and leadership at a national level. Lack of adequate resources channelled into the correct areas is also a key, if depressingly obvious, issue -the WHO is not sufficiently well funded to maintain a strong focus on scaling up and improving access to HIV/AIDS treatment, a situation not helped by the failure of the G8 nations to adequately honour their 2005 Gleneagles funding commitments. Increased price competition, by allowing generic competition, is needed to make essential medicines and treatment affordable for all. Yet the ongoing development of additional restrictions in global trade that effectively limit the production of lowcost generic pharmaceuticals and threaten the availability of affordable drugs is a significant obstacle to progress towards universal access to HIV/AIDS interventions.
As detailed in a recent statement from the International Treatment Preparedness Coalition, given the will, all of these problems are surmountable. All countries need to submit fully costed universal access plans in a timely fashion and the WHO must ensure that these plans are both ambitious and realistic. In addition, to ensure that the WHO has the resources to fulfil a leadership role on these issues, the necessary financial resources from various sources -multilateral, bilateral and private -need to be made available. Finally, each of the G8 member nations must ensure that the upcoming 2007 G8 process, hosted by Germany in June, is used to place HIV/AIDS treatment access back on top of the agenda, and that clear and specific steps are taken to guarantee that the promises made in 2005 are finally delivered on behalf of the affected communities across the world. It is morally and politically imperative that the G8 deliver on all these areas for an effective, comprehensive and sustainable HIV epidemic response.
